Report
Report
State economic scorecard 2026
The scorecard assesses and ranks the performance of each Australian state across ten economic indicators: annual growth in per capita gross state product, annual wage growth, jobs growth, retail turnover, tax burden, debt burden, productivity growth, business investment, rental affordability and energy affordability. Western Australia is the best performing state and New South Wales the...
Report
Blue report: regional breakdown – April 2026
This report provides an analysis of how the November 2025 Medicare changes have impacted general practitioner accessibility across metropolitan and regional Australia, providing region-based insights. It compares the capital city and non-capital city areas of each state to determine whether accessibility gaps remain and exactly where they are. The trends are mixed but encouraging.
Report
For the people: future-proofing Australia’s democracy
Australia is one of the world’s leading democracies, but cannot take it for granted. This report shows that democracy is backsliding globally, and the world order in which Australia has flourished is being seriously tested. The report identifies five priorities for Australia to build a better and more resilient democracy.
Report
Workforce pressures facing the food and grocery manufacturing sector
This report examines workforce pressures facing Australia’s food and grocery manufacturing sector, setting a focus for long-term solutions. The report provides a macro assessment of workforce challenges affecting the sector. Key occupations in focus for this report include food and drink factory workers; packers; forklift drivers; purchasing and supply logistics clerks; and manufacturing production managers.
Report
Still out of pocket: why 43 per cent of Australians are missing out on cheaper medicines
The Australian Government’s Cheaper Medicines policy commenced in January 2026. Despite the reforms starting to take effect, there is a growing risk that many Australians who rely on non-PBS subsidised medicines will continue to be impacted by out-of-pocket costs. This report considers this challenge and outlines a way forward to expand the cheaper medicines program.